Togni reagent II

1-phenyl-1H-1,2,3-triazol-5-amine

[(4-iodophenyl)methyl](methyl)amine hydrochloride

3-(4-(tert-butyl)pyridin-1-ium-1-yl)propane-1-sulfonate

1-hydroxy-1-oxo-3H-1lambda5,2-benziodaoxol-3-one; pyridine

(3aS,3'R,4S,4'S,5'R,6R,6'R,7S,7aS)-4-(((1R,2S,3R,5S,6R)-3-amino-2,6-dihydroxy-5-(methylamino)cyclohexyl)oxy)-6'-((S)-1-amino-2-hydroxyethyl)-6-(hydroxymethyl)octahydro-3aH-spiro[[1,3]dioxolo[4,5-c]pyran-2,2'-pyran]-3',4',5',7-tetraol

6-amino-1,3,5-triazin-2(1H)-one

4-fluoropyridin-3-amine

1-{1-[(tert-butoxy)carbonyl]azepan-4-yl}-1H-1,2,3-triazole-4-carboxylic acid

Brivaracetam

(Z)-4-(1-(4-(2-(dimethylamino)ethoxy)phenyl)-2-phenylbut-1-en-1-yl)phenol

(4R,4aR,5R,6R,7S,9S,10R,10aR,11S)-2-amino-6-(hydroxymethyl)-1,4,4a,5,6,7,9,10-octahydro-5,9-epoxy-7,10a-methanooxocino[4,5-d]pyrimidine-4,6,9,10,11-pentaol

1-Hydroxy-1,2-benziodoxol-3(1H)-one 1-oxide

(4aS,6aS,6bR,8R,8aR,9R,10R,11R,12aR,12bR,14bS)-8,10,11-trihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid

(S)-2-((2-((S)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide

2-cyclopentyl-2-methoxyethan-1-amine

3-(benzo[d][1,3]dioxol-5-yl)-5-(3-bromophenyl)-1H-pyrazole

2-amino-7-methyl-3H-purin-6(7H)-one

(chloromethanetriyl)tribenzene

1H-pyrazole-1-carboximidamide hydrochloride